Brookfield Asset Management (NYSE:BAM) and Elbit Imaging (NASDAQ:EMITF) are both finance companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, risk, institutional ownership, earnings and analyst recommendations.
This table compares Brookfield Asset Management and Elbit Imaging’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Brookfield Asset Management||5.10%||3.52%||1.34%|
This is a breakdown of recent ratings for Brookfield Asset Management and Elbit Imaging, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Brookfield Asset Management||0||0||6||0||3.00|
Brookfield Asset Management currently has a consensus target price of $51.75, indicating a potential upside of 17.83%. Given Brookfield Asset Management’s higher probable upside, equities analysts plainly believe Brookfield Asset Management is more favorable than Elbit Imaging.
Brookfield Asset Management pays an annual dividend of $0.60 per share and has a dividend yield of 1.4%. Elbit Imaging does not pay a dividend. Brookfield Asset Management has raised its dividend for 6 consecutive years.
Earnings & Valuation
This table compares Brookfield Asset Management and Elbit Imaging’s gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Brookfield Asset Management||$40.79 billion||1.07||$1.46 billion||N/A||N/A|
|Elbit Imaging||$225.79 million||0.07||-$97.50 million||N/A||N/A|
Brookfield Asset Management has higher revenue and earnings than Elbit Imaging.
Institutional and Insider Ownership
60.1% of Brookfield Asset Management shares are held by institutional investors. Comparatively, 40.9% of Elbit Imaging shares are held by institutional investors. 59.4% of Elbit Imaging shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Risk and Volatility
Brookfield Asset Management has a beta of 1.03, indicating that its stock price is 3% more volatile than the S&P 500. Comparatively, Elbit Imaging has a beta of -0.19, indicating that its stock price is 119% less volatile than the S&P 500.
Brookfield Asset Management beats Elbit Imaging on 12 of the 13 factors compared between the two stocks.
About Brookfield Asset Management
Brookfield Asset Management Inc. is a publicly owned asset management holding company. Through its subsidiaries, the firm invests in the property, power, and infrastructure sectors. Its property business includes owning and managing office properties, developing master planned residential communities, and offering clients bridge and mezzanine lending, alternative assets funds, and financial and advisory services. Through its subsidiaries, the firm operates hydroelectric power facilities, interconnections and transmission facilities in Northeast North America, and development of wind power in Canada. Through its subsidiaries, it invests in specialty funds including private equity and makes direct investments in real estate, energy, and resource assets. The firm launches and manages equity and fixed income mutual funds. It also manages real estate and hedge funds. The firm invests in equity and fixed income markets across the globe. It was formerly known as Brascan Corp. Brookfield Asset Management Inc. is based in Toronto, Canada with additional offices in Bogota, Colombia, Rio de Janeiro, Brazil, Calgary, Canada, Dubai, United Arab Emirates, Gatineau, Canada, Hong Kong, Hong Kong, London, United Kingdom, Melbourne, Australia, Montreal, Canada, Mumbai, India, New York City, Perth, Australia, Shanghai, China, and Sydney, Australia.
About Elbit Imaging
Elbit Imaging Ltd., together with its subsidiaries, engages in medical industries and plots sale businesses in India, and Central and Eastern Europe. It is involved in the research and development, production, and marketing of treatment-oriented medical systems, including magnetic resonance imaging for the purpose of performing noninvasive treatments in human beings; and products designated for certain cancer diseases. The company was founded in 1996 and is headquartered in Petach Tikva, Israel.
Receive News & Ratings for Brookfield Asset Management Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brookfield Asset Management and related companies with MarketBeat.com's FREE daily email newsletter.